Pfizer Inc.
PFE
$24.86
$0.291.18%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 63.83B | 62.46B | 63.63B | 60.43B | 56.22B |
| Total Other Revenue | -- | -- | -- | 1.91B | 1.91B |
| Total Revenue | 63.83B | 62.46B | 63.63B | 60.43B | 56.22B |
| Cost of Revenue | 16.71B | 15.97B | 16.42B | 11.74B | 15.78B |
| Gross Profit | 47.13B | 46.49B | 47.21B | 48.69B | 40.45B |
| SG&A Expenses | 14.06B | 14.32B | 14.76B | 14.15B | 14.15B |
| Depreciation & Amortization | 5.09B | 5.19B | 5.29B | 5.19B | 5.06B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.15B | 46.01B | 47.29B | 41.68B | 45.70B |
| Operating Income | 17.69B | 16.46B | 16.34B | 18.75B | 10.53B |
| Income Before Tax | 10.53B | 7.39B | 8.02B | 3.90B | -4.16B |
| Income Tax Expenses | -235.00M | -510.00M | -28.00M | -402.00M | -1.60B |
| Earnings from Continuing Operations | 10.77K | 7.90K | 8.05K | 4.31K | -2.56K |
| Earnings from Discontinued Operations | 24.00M | 16.00M | 11.00M | -22.00M | -2.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.00M | -29.00M | -31.00M | -32.00M | -30.00M |
| Net Income | 10.75B | 7.88B | 8.03B | 4.25B | -2.60B |
| EBIT | 17.69B | 16.46B | 16.34B | 18.75B | 10.53B |
| EBITDA | 24.46B | 23.33B | 23.34B | 25.62B | 17.21B |
| EPS Basic | 1.89 | 1.39 | 1.42 | 0.75 | -0.46 |
| Normalized Basic EPS | 1.73 | 1.59 | 1.55 | 1.88 | 1.07 |
| EPS Diluted | 1.89 | 1.39 | 1.42 | 0.74 | -0.47 |
| Normalized Diluted EPS | 1.72 | 1.58 | 1.54 | 1.87 | 1.07 |
| Average Basic Shares Outstanding | 22.69B | 22.68B | 22.66B | 22.64B | 22.62B |
| Average Diluted Shares Outstanding | 22.82B | 22.81B | 22.80B | 22.75B | 22.69B |
| Dividend Per Share | 1.70 | 1.69 | 1.68 | 1.67 | 1.66 |
| Payout Ratio | 66.94% | 121.49% | 118.44% | 222.18% | -361.50% |